MicroRNAs for the Prediction of Early Response to Sorafenib Treatment in Human Hepatocellular Carcinoma

Naoshi Nishida; Tadaaki Arizumi; Satoru Hagiwara; Hiroshi Ida; Toshiharu Sakurai; Masatoshi Kudo

doi:10.1159/000449475

Related publications

Dataset

Supplementary Material for: MicroRNAs for the Prediction of Early Response to Sorafenib Treatment in Human Hepatocellular Carcinoma

Naoshi Nishida, Tadaaki Arizumi, Sachiko Hagiwara, Hiroshi Ida, Toshiharu Sakurai, Masatoshi Kudo

Article2015

Molecular Mechanism and Prediction of Sorafenib Chemoresistance in Human Hepatocellular Carcinoma

Naoshi Nishida, Masayuki Kitano, Toshiharu Sakurai, Masatoshi Kudo

Article2021

MicroRNAs as Potential Predictors of Response to CDK4/6 Inhibitor Treatment

Αngeliki Andrikopoulou, Almog Shalit, Eleni Zografos, Konstantinos Koutsoukos, Anna-Maria Korakiti, Michalis Liontos, Meletios A Dimopoulos, Flora Zagouri

Dataset

Supplementary Material for: Treatment Stage Migration Maximizes Survival Outcomes in Patients with Hepatocellular Carcinoma Treated with Sorafenib: An Observational Study

Clarence Yen, Ratnadeep Sharma, Lorenza Rimassa, T. Arizumi, D. Bettinger, Huay Yee Choo, Tiziana Pressiani, M.E. Burlone, M. Pirisi, Laura Giordano, Abdulkarim Abdulrahman, Masatoshi Kudo, Robert Thimme, J.W. Park, David J. Pinato

Article2017

Treatment Stage Migration Maximizes Survival Outcomes in Patients with Hepatocellular Carcinoma Treated with Sorafenib: An Observational Study

Clarence Yen, Rohini Sharma, Lorenza Rimassa, Tadaaki Arizumi, Dominik Bettinger, Huay Yee Choo, Tiziana Pressiani, Michela Emma Burlone, Mario Pirisi, Laura Giordano, Anisa Abdulrahman, Masatoshi Kudo, Robert Thimme, Joong Won Park, David J. Pinato